Valsartan Tablet
Product Images NDC 50228-133

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 50228-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Valsartan Tablets Usp 01)

Label for Valsartan Tablets, USP 320 mg oral tablets by ScieGen Pharmaceuticals, Inc. The label indicates a bottle containing 500 tablets with a National Drug Code (NDC) 50228-132-05. Storage instructions specify protection from moisture and temperature control between 20° to 25°C, with permitted excursions. The label highlights prescription use only and includes typical caution about keeping medication out of children's reach.*

FDA Label Image

1 (Valsartan Tablets Usp 02)

Label for Valsartan tablets, USP 320 mg, manufactured by ScieGen Pharmaceuticals, Inc. The label includes dosage and storage instructions, a barcode, and a count of 30 tablets. It specifies the product as a prescription drug (Rx Only) and provides the NDC 50228-132-30. The label emphasizes keeping medication out of reach of children.*

FDA Label Image

1 (Valsartan Tablets Usp 03)

Label for Valsartan Tablets, USP 160 mg oral tablets by ScieGen Pharmaceuticals, Inc. The label states storage instructions, dosage note, manufacturer info, package contains 1,000 tablets, and includes the NDC 50228-133-10 with a barcode.*

FDA Label Image

1 (Valsartan Tablets Usp 04)

Label for Valsartan Tablets, USP 160 mg, a prescription oral tablet manufactured by ScieGen Pharmaceuticals, Inc. The label indicates packaging of 30 tablets and includes storage instructions and a barcode. It also states that the medication must be kept out of reach of children and dispensed in a tight container.*

FDA Label Image

1 (Valsartan Tablets Usp 05)

Label for Valsartan Tablets, USP 80 mg by ScieGen Pharmaceuticals, Inc. The label indicates the product contains 80 mg of valsartan per film-coated tablet, with a package size of 1,000 tablets. It includes storage instructions (20° to 25°C, excursions to 15° to 30°C), a caution to keep medication away from children, and notes it is Rx only. The label displays the NDC number 50228-134-10 and the ScieGen logo.*

FDA Label Image

1 (Valsartan Tablets Usp 06)

Label for Valsartan Tablets, USP 80 mg by ScieGen Pharmaceuticals, Inc. The label states the tablet contains 80 mg of valsartan and the package contains 30 tablets. Includes storage instructions, dosage advisory to read prescribing information, and a barcode. The label notes the product is Rx only and manufactured by ScieGen Pharmaceuticals in Hauppauge, NY.*

FDA Label Image

1 (Valsartan Tablets Usp 07)

Label for Valsartan Tablets, USP 40 mg from ScieGen Pharmaceuticals, Inc. The label specifies each film-coated tablet contains 40 mg of valsartan. The package contains 1,000 tablets with an oral dosage form. Storage instructions and warnings are included, along with the NDC 50228-135-10 and a barcode.*

FDA Label Image

1 (Valsartan Tablets Usp 08)

Valsartan 40 mg Tablets, USP label from ScieGen Pharmaceuticals, Inc. It indicates one tablet contains 40 mg of valsartan, with a package size of 30 tablets. The label includes storage instructions, dosage directions to read accompanying prescribing information, and a barcode.*

FDA Label Image

1 (Valsartan Tablets Usp 1)

Chemical structure diagram of Valsartan, illustrating the molecular arrangement of atoms including functional groups characteristic of this active ingredient.*

FDA Label Image

1 (Valsartan Tablets Usp 2)

A forest plot titled 'Effects on Mortality Amongst Subgroups in VALIANT' comparing mortality effects of Valsartan versus Captopril across various patient subgroups. The horizontal axis shows a scale from 0.5 to 1.5, indicating favor toward Valsartan or Captopril. Subgroups include age, sex, race, region, and beta-blocker use, each with markers and confidence intervals around the value 1.0, representing relative effects on mortality.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.